239 related articles for article (PubMed ID: 6183880)
1. A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.
Polano MK; van der Rhee HJ; van der Schroeff JG
Acta Derm Venereol; 1982; 62(4):361-4. PubMed ID: 6183880
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double-blind trial.
van der Rhee HJ; Tijssen JG; Herrmann WA; Waterman AH; Polano MK
Br J Dermatol; 1980 Feb; 102(2):203-12. PubMed ID: 6992834
[TBL] [Abstract][Full Text] [Related]
3. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
Mahrle G; Meyer-Hamme S; Ippen H
Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
[TBL] [Abstract][Full Text] [Related]
5. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
[TBL] [Abstract][Full Text] [Related]
7. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
[TBL] [Abstract][Full Text] [Related]
8. [Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis].
Rüst O; Tufli T
Schweiz Med Wochenschr; 1979 Dec; 109(48):1921-5. PubMed ID: 161414
[TBL] [Abstract][Full Text] [Related]
9. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.
Chieregato GC; Leoni A
Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403
[TBL] [Abstract][Full Text] [Related]
10. Oral retinoid for psoriasis. A report of a double blind study.
Pettit JH
Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035
[TBL] [Abstract][Full Text] [Related]
11. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
Bjerke JR; Geiger JM
Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
[TBL] [Abstract][Full Text] [Related]
12. Tigason (etretinate) treatment in psoriatic arthritis.
Ciompi ML; Bazzichi L; Marotta G; Pasero G
Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251
[TBL] [Abstract][Full Text] [Related]
13. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
14. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
[TBL] [Abstract][Full Text] [Related]
15. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
Thivolet J; Robart S; Vignon E
Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
[TBL] [Abstract][Full Text] [Related]
16. [Congenital pachyonychia treated by oral retinoid].
Rondón Lugo AJ
Med Cutan Ibero Lat Am; 1982; 10(6):395-8. PubMed ID: 6764243
[TBL] [Abstract][Full Text] [Related]
17. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
[TBL] [Abstract][Full Text] [Related]
18. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
[TBL] [Abstract][Full Text] [Related]
19. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
[No Abstract] [Full Text] [Related]
20. [Oral treatment of lamellar ichthyosis (non-bullous congenital ichthyosiform erythroderma) with an aromatic retinoid (author's transl)].
Frenk E
Dermatologica; 1981; 162(2):91-103. PubMed ID: 7018943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
